Lynk Pharmaceuticals Co., Ltd.

About Lynk Pharmaceuticals Co., Ltd.

Lynk Pharmaceuticals is a clinical-stage innovative drug development company dedicated to discovering and developing new drugs for the treatment of cancer, as well as immune and inflammatory diseases. Founded by experienced drug development experts and executives from Pfizer, Merck, and Johnson & Johnson, Lynk aims to become a market leader by addressing unmet medical needs through innovative therapies.

Products & Services

Innovative therapies for cancer treatment - New drugs being developed to address unmet medical needs in oncology.

Innovative therapies for immune diseases - New drugs targeting immune system disorders.

Specialties

Cancer treatment drug development Immune disease drug development Inflammatory disease drug development Clinical-stage drug innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 44413793 MR: - FA: 322 million RMB FAN: 44413793	D: 2023-09-21 FD: 2023-09-21	5 investors
2	RT: Series C1 T: - FT: Series C1	A: 28200000 MR: - FA: 200 million RMB FAN: 28200000	D: 2023-05-31 FD: 2023-05-31	3 investors

Series C Latest

2023-09-21

$44.4M

5 investors (Pro only)

Series C1 2023-05-31

$28.2M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

W

Wang Jun

Co-founder & Chief Scientific Officer

M

Michael Vazquez

Co-Founder & Senior Vice President & Head of Chemistry Department

C

Chen Wei

Co-Founder & Chief Operating Officer

W

Wu Yu

Chief Development Officer

M

Michael Kahn

Advisory Board Chairman

D

Dashyant Dhanak

Executive Vice President and Chief Scientific Officer

View 5 more team members with Pro

Unlock Full Team Directory

Recent News